±¹¸³¾Ï¼¾ÅÍ ¹ÚÁß¿ø ¹Ú»ç GSK Çмú³í¹®»ó ¼ö»ó

´º½ºÀÏÀÚ: 2008³â05¿ù28ÀÏ 00½Ã00ºÐ

¹ÚÁß¿ø ±¹¸³¾Ï¼¾ÅÍ °£¾Ï¼¾ÅÍÀåÀÌ Áö³­ 17ÀÏ ´ëÇÑ°£ÇÐȸ¿¡¼­ ‘VEGF À¯ÀüÀÚ ´ÙÇü¼ºÀÌ °£¼¼Æ÷¾ÏÁ¾ ȯÀÚ »ýÁ¸¿¡ ¹ÌÄ¡´Â ¿µÇâ(Association between VEGF gene polymorphisms and survival in hepatocellular carcinoma patients)’À̶ó´Â ³í¹®À¸·Î GSK Çмú³í¹®»óÀ» ¼ö»óÇß´Ù.

 

 

 

 

 

 

 

 


ÀÌ ´º½ºÅ¬¸®ÇÎÀº BKT´º½º{www.bktimes.net}¿¡¼­ ¹ßÃéµÈ ³»¿ëÀÔ´Ï´Ù.